Rethinking retention in treatment of opioid dependence—The eye of the beholder
Sábháilte in:
Vogel, M., et al., Rethinking retention in treatment of opioid dependence—The eye of the beholder. International Journal of Drug Policy, vol. 39, 2017, p. 109-113.
Ref.
520925
Suíomh:
SIIS Archivo (R.1114)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Heroína, Reducción de daños, Programas de mantenimiento, Retención, Recetas médicas, Efectos, Resultados
Drogodependencias, Drogas ilegales, Opiáceos, Heroína, Reducción de daños, Programas de mantenimiento, Retención, Recetas médicas, Efectos, Resultados
Míreanna comhchosúla: Rethinking retention in treatment of opioid dependence—The eye of the beholder
- TREATMENT PRACTICES AND PERCEIVED CHALLENGES FOR EUROPEAN PHYSICIANS TREATING OPIOID DEPENDENCE
- TREATING HEROIN DEPENDENCE WITH DIAMORPHINE (PHARMACEUTICAL HEROIN). EN: PHARMACOTHERAPIES FOR THE TREATMENT OF OPIOID DEPENDENCE. EFFICACY, COST-EFFECTIVENESS AND IMPLEMENTATION GUIDELINES
- ANTIDEPRESSANT TREATMENT DOES NOT IMPROVE BUPRENORPHINE RETENTION AMONG OPIOID DEPENDENT PERSONS
- A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
- Determinants of buprenorphine treatment for opioid dependence
- Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial